ArticleArchives of medical science : AMS2025
Establishing reference intervals for serum glutathione reductase in healthy adults.
Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The effects of Pistacia atlantica seed-canola oil blend on serum oxidative stress and lipid biomarkers in adults with metabolic syndrome.Scientific reports · 2026Article
- Reference intervals for plasma IFN-α, TNF-α, IL-12p70, and IFN-γ by flow cytometry in healthy adults from eastern China: a single-center study.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Glutathione reductase (GR) is a key enzyme that catalyzes the reduction of oxidized glutathione to its reduced form, playing a vital role in protecting cells from oxidative damage caused by the accumulation of reactive oxygen species. This study employed the ultraviolet enzymatic method to measure serum GR activity, aiming to investigate its distribution among apparently healthy adults and preliminarily establish reference intervals for serum GR. Material and methods: A total of 6,180 apparently healthy individuals participated in this study. Serum GR activity was measured using the AU5800 fully automated biochemical analyzer and its corresponding commercial kit. The Kolmogorov-Smirnov test was used to analyze the distribution of serum GR activity. Following the guidelines of C28-A3 and WS/T 402-2024, the reference interval for serum GR was determined using the bilateral percentile method, covering the range from the 2.5th to the 97.5th percentile. Results: Serum GR activity in this study exhibited a non-normal distribution. Significant gender-based differences in GR activity were observed, while no significant variations were found across different age groups. Based on these findings, gender-specific reference intervals for serum GR were established: 26.6-51.8 U/l for males and 29.7-55.3 U/l for females. Conclusions: This study is the first to establish gender-specific reference intervals for serum GR in apparently healthy adults. These intervals provide essential guidance for health screening and improve the diagnosis and management of related clinical conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.